Market closedNon-fractional

Clene/CLNN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Clene

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).

Ticker

CLNN

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Salt Lake City, United States

Employees

84
Website
clene.com

Clene Metrics

BasicAdvanced
$45M
Market cap
-
P/E ratio
-$0.41
EPS
-
Beta
-
Dividend rate
$45M
1.226
1.123
276.853
760.788
-8.24%
-57.44%
-3,702.24%
66.394
10.54
10.54
-1.465
12.73%
-0.01%
21.11%
-40.31%

What the Analysts think about Clene

Analyst Ratings

Majority rating from 5 analysts.
Buy

Clene Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
-100.00%
Net income
-$11M
8.91%
Profit margin
0.00%
-100.00%

Clene Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 12.50%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.29
-$0.02
-$0.06
-$0.09
-
Expected
-$0.12
-$0.09
-$0.07
-$0.08
-$0.08
Surprise
136.05%
-77.78%
-17.24%
12.50%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Clene stock?

Clene (CLNN) has a market cap of $45M as of July 06, 2024.

What is the P/E ratio for Clene stock?

The price to earnings (P/E) ratio for Clene (CLNN) stock is 0 as of July 06, 2024.

Does Clene stock pay dividends?

No, Clene (CLNN) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Clene dividend payment date?

Clene (CLNN) stock does not pay dividends to its shareholders.

What is the beta indicator for Clene?

Clene (CLNN) does not currently have a Beta indicator.

Buy or sell Clene stock

Buy or sell Clene stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing